Filtered By:
Cancer: Prostate Cancer
Countries: Japan Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 220 results found since Jan 2013.
The prognosis of patients with prostate cancer receiving permanent seed implantation stratified by prostate volume: should we be reluctant to treat with brachytherapy because of a very small prostate ( & lt;15 cc)?
CONCLUSIONS: Our results obtained by analyzing a very large Japanese prospective database showed no difference in treatment outcomes according to PV (<15 cc, 15-20 cc, and ˃20 cc). Our study confirmed that PI in small prostates (even <15 cc) remains an effective treatment option.PMID:37597804 | DOI:10.1016/j.radonc.2023.109855
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - August 19, 2023 Category: Radiology Authors: Koji Masui Norihisa Katayama Atsunori Yorozu Takashi Kikuchi Satoshi Higashide Shinsuke Kojima Shiro Saito Source Type: research
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort
CONCLUSIONS: Increasing age could be a predictive factor for adverse pathology. Our findings suggest that older men could potentially derive advantages from adhering to the examination schedule in active surveillance.PMID:37496400 | DOI:10.1093/jjco/hyad088
Source: Clinical Prostate Cancer - July 27, 2023 Category: Cancer & Oncology Authors: Yoichiro Tohi Ryou Ishikawa Takuma Kato Jimpei Miyakawa Ryuji Matsumoto Keiichiro Mori Koji Mitsuzuka Junichi Inokuchi Masafumi Matsumura Kenichiro Shiga Hirohito Naito Yasuo Kohjimoto Norihiko Kawamura Masaharu Inoue Shusuke Akamatsu Naoki Terada Yoshiyu Source Type: research
A multicenter, retrospective observational study investigating baseline characteristics and clinical outcomes in patients with hormone-sensitive prostate cancer treated with primary androgen deprivation therapy
CONCLUSIONS: This study clarified patient characteristics and long-term effectiveness of primary androgen deprivation therapy in real-world clinical practice. Japanese urologists appear to select appropriate primary androgen deprivation therapy based on patient background and tumour characteristics, with degarelix largely reserved for higher risk patients.PMID:37408443 | DOI:10.1093/jjco/hyad068
Source: Clinical Prostate Cancer - July 6, 2023 Category: Cancer & Oncology Authors: Satoru Taguchi Mizuki Onozawa Shiro Hinotsu Taketo Kawai Takeshi Mitomi Satoshi Uno Haruki Kume Source Type: research
Nomogram Predicting Locally Advanced Prostate Cancer in Patients with Clinically Organ-Confined Disease Who Underwent Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)
CONCLUSIONS: We developed a clinically applicable nomogram with external validation to predict the probability of locally advanced prostate cancer in patients undergoing robot-assisted radical prostatectomy.PMID:37338747 | DOI:10.1245/s10434-023-13747-2
Source: Ann Oncol - June 20, 2023 Category: Cancer & Oncology Authors: Makoto Kawase Takayuki Goto Shin Ebara Tomoyuki Tatenuma Takeshi Sasaki Takuma Ishihara Yoshinori Ikehata Akinori Nakayama Masahiro Toide Tatsuaki Yoneda Kazushige Sakaguchi Jun Teishima Takashi Kobayashi Kazuhide Makiyama Takahiro Inoue Hiroshi Kitamura Source Type: research
Prescription patterns of analgesics in cancer patients with bone metastases in Japan: a retrospective database study
CONCLUSION: In Japanese cancer patients with bone metastases, acetaminophen, NSAIDs, and weak or strong opioids were commonly used; their use increased after SREs developed. Opioid use increased closer to death.PMID:37314600 | DOI:10.1007/s10147-023-02365-3
Source: Clinical Prostate Cancer - June 14, 2023 Category: Cancer & Oncology Authors: Shingo Sato Hideyuki Tomitori Atsushi Okawa Kyoko Akano Source Type: research
Impact of cancer and other causes of death on mortality of cancer patients: A study based on Japanese population-based registry data
Int J Cancer. 2023 Jun 6. doi: 10.1002/ijc.34610. Online ahead of print.ABSTRACTCancer registry data provide a very important source of information for improving our understanding of the epidemiology of various cancers. In this work, we estimated the 5-year crude probabilities of death from cancer and from other causes for five common cancers, namely stomach, lung, colon-rectum, prostate and breast, in Japan, using population-based registry data. Based on data on 344 676 patients diagnosed with one of these cancers between 2006 and 2008 in 21 prefectures participating in the Monitoring of Cancer Incidence in Japan (MCIJ) a...
Source: Cancer Control - June 6, 2023 Category: Cancer & Oncology Authors: Hadrien Charvat Keisuke Fukui Tomohiro Matsuda Kota Katanoda Yuri Ito Source Type: research
Screening practices of cancer survivors and individuals whose family or friends had a cancer diagnoses-a nationally representative cross-sectional survey in Japan (INFORM Study 2020)
CONCLUSIONS: A cancer diagnosis in oneself or family or friend influences an individual's health-related belief and risk perception, which can increase the likelihood of cancer screening.IMPLICATIONS FOR CANCER SURVIVORS: Targeted and tailored communication strategies can increase awareness of cancer screening.PMID:37041402 | DOI:10.1007/s11764-023-01367-4
Source: Cancer Control - April 11, 2023 Category: Cancer & Oncology Authors: Miki Akiyama Noriyuki Ishida Hiroyasu Takahashi Miyako Takahashi Aki Otsuki Yasunori Sato Junko Saito Akiko Yaguchi-Saito Maiko Fujimori Yuki Kaji Taichi Shimazu INFORM Study Group Source Type: research
Clinical practice of UroVysion ® urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette-Guerin
This study was the first to report the Japanese real-world practice of the UroVysion test, demonstrating relatively low positive rate as compared to the previous reports from other countries. Further clinical evidence from other Japanese institutes needs to be accumulated to update the true value of this test.PMID:37039281 | DOI:10.1093/jjco/hyad029
Source: Clinical Prostate Cancer - April 11, 2023 Category: Cancer & Oncology Authors: Makito Miyake Shunta Hori Tomomi Fujii Nobutaka Nishimura Yuki Oda Tatsuki Miyamoto Mitsuru Tomizawa Takuto Shimizu Kenta Ohnishi Yosuke Morizawa Daisuke Gotoh Yasushi Nakai Kazumasa Torimoto Nobumichi Tanaka Kiyohide Fujimoto Source Type: research
